Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Schizophrenia

  Free Subscription


Articles published in Neuropsychopharmacology

Retrieve available abstracts of 34 articles:
HTML format
Text format



Single Articles


    August 2017
  1. LEE M, Balla A, Sershen H, Sehatpour P, et al
    Rodent Mismatch Negativity (MMN)/Theta Neuro-Oscillatory Response as a Translational Neurophysiological Biomarker for N-Methyl-D-Aspartate Receptor-Based New Treatment Development in Schizophrenia.
    Neuropsychopharmacology. 2017 Aug 17. doi: 10.1038/npp.2017.
    PubMed     Text format     Abstract available


    July 2017
  2. BRUCATO G, Appelbaum PS, Lieberman JA, Wall MM, et al
    A Longitudinal Study of Violent Behavior in a Psychosis-Risk Cohort.
    Neuropsychopharmacology. 2017 Jul 26. doi: 10.1038/npp.2017.
    PubMed     Text format     Abstract available


    June 2017
  3. COSGROVE D, Mothersill O, Kendall K, Konte B, et al
    Cognitive Characterization of Schizophrenia Risk Variants Involved in Synaptic Transmission: Evidence of CACNA1C's Role in Working Memory.
    Neuropsychopharmacology. 2017 Jun 13. doi: 10.1038/npp.2017.
    PubMed     Text format     Abstract available


  4. HAFIZI S, Da Silva T, Gerritsen C, Kiang M, et al
    Imaging Microglial Activation in Individuals at Clinical High Risk for Psychosis: An In-Vivo PET Study with [18F]FEPPA.
    Neuropsychopharmacology. 2017 Jun 12. doi: 10.1038/npp.2017.
    PubMed     Text format     Abstract available


  5. DOYLE GA, Crist RC, Karatas ET, Hammond MJ, et al
    Analysis of LINE-1 Elements in DNA from Postmortem Brains of Individuals with Schizophrenia.
    Neuropsychopharmacology. 2017 Jun 6. doi: 10.1038/npp.2017.
    PubMed     Text format     Abstract available


    April 2017
  6. RABIN RA, Barr MS, Goodman MS, Herman Y, et al
    Effects of Extended Cannabis Abstinence on Cognitive Outcomes in Cannabis Dependent Patients with Schizophrenia versus Non-Psychiatric Controls.
    Neuropsychopharmacology. 2017 Apr 26. doi: 10.1038/npp.2017.
    PubMed     Text format     Abstract available


  7. LIGHT GA, Zhang W, Joshi YB, Bhakta S, et al
    Single-Dose Memantine Improves Cortical Oscillatory Response Dynamics in Patients with Schizophrenia.
    Neuropsychopharmacology. 2017 Apr 20. doi: 10.1038/npp.2017.
    PubMed     Text format     Abstract available


  8. EISENBERG DP, Yankowitz L, Ianni AM, Rubinstein DY, et al
    Presynaptic Dopamine Synthesis Capacity in Schizophrenia and Striatal Blood Flow Change During Antipsychotic Treatment and Medication-Free Conditions.
    Neuropsychopharmacology. 2017 Apr 7. doi: 10.1038/npp.2017.
    PubMed     Text format     Abstract available


    March 2017
  9. SARPAL DK, Robinson DG, Fales C, Lencz T, et al
    Relationship between Duration of Untreated Psychosis and Intrinsic Corticostriatal Connectivity in Patients with Early Phase Schizophrenia.
    Neuropsychopharmacology. 2017 Mar 15. doi: 10.1038/npp.2017.
    PubMed     Text format     Abstract available


  10. POGORELOV VM, Rodriguiz RM, Cheng J, Huang M, et al
    5-HT2C Agonists Modulate Schizophrenia-Like Behaviors in Mice.
    Neuropsychopharmacology. 2017 Mar 15. doi: 10.1038/npp.2017.
    PubMed     Text format     Abstract available


    February 2017
  11. ZHEUTLIN AB, Jeffries CD, Perkins DO, Chung Y, et al
    The Role of microRNA Expression in Cortical Development During Conversion to Psychosis.
    Neuropsychopharmacology. 2017 Feb 10. doi: 10.1038/npp.2017.
    PubMed     Text format     Abstract available


    January 2017
  12. PEREZ VB, Tarasenko M, Miyakoshi M, Pianka ST, et al
    Mismatch Negativity is a Sensitive and Predictive Biomarker of Perceptual Learning During Auditory Cognitive Training in Schizophrenia.
    Neuropsychopharmacology. 2017 Jan 31. doi: 10.1038/npp.2017.
    PubMed     Text format     Abstract available


  13. HO NF, Holt DJ, Cheung M, Iglesias JE, et al
    Progressive Decline in Hippocampal CA1 Volume in Individuals at Ultra-High-Risk for Psychosis Who do not Remit: Findings from the Longitudinal Youth at Risk Study.
    Neuropsychopharmacology. 2017 Jan 12. doi: 10.1038/npp.2017.
    PubMed     Text format     Abstract available


    December 2016
  14. PETIT EI, Michalak Z, Cox R, O'Tuathaigh CM, et al
    Dysregulation of Specialized Delay/Interference-Dependent Working Memory Following Loss of Dysbindin-1A in Schizophrenia-Related Phenotypes.
    Neuropsychopharmacology. 2016 Dec 16. doi: 10.1038/npp.2016.
    PubMed     Text format     Abstract available


  15. YOUNG JW, Bismark AW, Sun Y, Zhang W, et al
    Neurophysiological Characterization of Attentional Performance Dysfunction in Schizophrenia Patients in a Reverse-Translated Task.
    Neuropsychopharmacology. 2016 Dec 5. doi: 10.1038/npp.2016.
    PubMed     Text format     Abstract available


    November 2016
  16. KIM E, Howes OD, Veronese M, Beck K, et al
    Presynaptic Dopamine Capacity in Patients with Treatment Resistant Schizophrenia Taking Clozapine: An [18F]DOPA PET Study.
    Neuropsychopharmacology. 2016 Nov 18. doi: 10.1038/npp.2016.
    PubMed     Text format     Abstract available


    October 2016
  17. GONG Q, Hu X, Pettersson-Yeo W, Xu X, et al
    Network-Level Dysconnectivity in Drug-Naive First Episode Psychosis: Dissociating Trans-Diagnostic and Diagnosis-Specific Alterations.
    Neuropsychopharmacology. 2016 Oct 26. doi: 10.1038/npp.2016.
    PubMed     Text format     Abstract available


    September 2016
  18. MILLER BJ, Goldsmith DR
    Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions.
    Neuropsychopharmacology. 2016 Sep 22. doi: 10.1038/npp.2016.
    PubMed     Text format     Abstract available


    August 2016
  19. WIJTENBURG SA, Wright SN, Korenic SA, Gaston FE, et al
    Altered Glutamate and Regional Cerebral Blood Flow Levels in Schizophrenia: A 1H-MRS and pCASL Study.
    Neuropsychopharmacology. 2016 Aug 26. doi: 10.1038/npp.2016.
    PubMed     Text format     Abstract available


  20. SCHOONOVER KE, McCollum LA, Roberts RC
    Protein Markers of Neurotransmitter Synthesis and Release in Postmortem Schizophrenia Substantia Nigra.
    Neuropsychopharmacology. 2016 Aug 23. doi: 10.1038/npp.2016.
    PubMed     Text format     Abstract available


    July 2016
  21. DE LEEUW M, Bohlken MM, Mandl RC, Hillegers MH, et al
    Changes in White Matter Organization in Adolescent Offspring of Schizophrenia Patients.
    Neuropsychopharmacology. 2016 Jul 21. doi: 10.1038/npp.2016.
    PubMed     Text format     Abstract available


    June 2016
  22. HAIG G, Wang D, Othman AA, Zhao J, et al
    The alpha7 Nicotinic Agonist ABT-126 in the Treatment of Cognitive Impairment Associated with Schizophrenia in Nonsmokers: Results from a Randomized Controlled Phase 2b Study.
    Neuropsychopharmacology. 2016 Jun 20. doi: 10.1038/npp.2016.
    PubMed     Text format     Abstract available


  23. PLITMAN E, Patel R, Chung JK, Pipitone J, et al
    Glutamatergic Metabolites, Volume and Cortical Thickness in Antipsychotic-Naive Patients with First-Episode Psychosis: Implications for Excitotoxicity.
    Neuropsychopharmacology. 2016 Jun 8. doi: 10.1038/npp.2016.
    PubMed     Text format     Abstract available


    May 2016
  24. CHIAPPELLI J, Postolache TT, Kochunov P, Rowland LM, et al
    Tryptophan Metabolism and White Matter Integrity in Schizophrenia.
    Neuropsychopharmacology. 2016 May 4. doi: 10.1038/npp.2016.
    PubMed     Text format     Abstract available


    April 2016
  25. ERYILMAZ H, Tanner AS, Ho NF, Nitenson AZ, et al
    Disrupted working Memory Circuitry in Schizophrenia: Disentangling fMRI Markers of Core Pathology Versus other Aspects of Impaired Performance.
    Neuropsychopharmacology. 2016 Apr 22. doi: 10.1038/npp.2016.
    PubMed     Text format     Abstract available


  26. SCHWEHM A, Robinson DG, Gallego JA, Karlsgodt KH, et al
    Age and Sex Effects on White Matter Tracts in Psychosis from Adolescence though Middle Adulthood.
    Neuropsychopharmacology. 2016 Apr 12. doi: 10.1038/npp.2016.
    PubMed     Text format     Abstract available


  27. FRYER SL, Roach BJ, Wiley K, Loewy RL, et al
    Reduced Amplitude of Low-Frequency Brain Oscillations in the Psychosis Risk Syndrome and Early Illness Schizophrenia.
    Neuropsychopharmacology. 2016 Apr 12. doi: 10.1038/npp.2016.
    PubMed     Text format     Abstract available


  28. GOONAWARDENA AV, Heiss J, Glavis-Bloom C, Trube G, et al
    Alterations in High-Frequency Neuronal Oscillations in a Cynomolgus Macaque Test of Sustained Attention Following NMDA Receptor Antagonism.
    Neuropsychopharmacology. 2016;41:1319-28.
    PubMed     Text format     Abstract available


    March 2016
  29. DU Y, Grace AA
    Amygdala Hyperactivity in MAM Model of Schizophrenia is Normalized by Peripubertal Diazepam Administration.
    Neuropsychopharmacology. 2016 Mar 22. doi: 10.1038/npp.2016.
    PubMed     Text format     Abstract available


  30. CASTRO VM, Roberson AM, McCoy TH, Wiste A, et al
    Stratifying Risk for Renal Insufficiency Among Lithium-Treated Patients: An Electronic Health Record Study.
    Neuropsychopharmacology. 2016;41:1138-43.
    PubMed     Text format     Abstract available


    February 2016
  31. ENWRIGHT JF, Sanapala S, Foglio A, Berry R, et al
    Reduced Labeling of Parvalbumin Neurons and Perineuronal Nets in the Dorsolateral Prefrontal Cortex of Subjects with Schizophrenia.
    Neuropsychopharmacology. 2016 Feb 12. doi: 10.1038/npp.2016.
    PubMed     Text format     Abstract available


    January 2016
  32. BALU DT, Li Y, Takagi S, Presti KT, et al
    An mGlu5 Positive Allosteric Modulator Rescues the Neuroplasticity Deficits in a Genetic Model of NMDA Receptor Hypofunction in Schizophrenia.
    Neuropsychopharmacology. 2016 Jan 7. doi: 10.1038/npp.2016.
    PubMed     Text format     Abstract available


  33. WEICKERT CS, Weickert TW
    Hormone modulation improves cognition in schizophrenia.
    Neuropsychopharmacology. 2016;41:384-5.
    PubMed     Text format    


    December 2015
  34. SEGARRA N, Metastasio A, Ziauddeen H, Spencer J, et al
    Abnormal Frontostriatal Activity during Unexpected Reward Receipt in Depression and Schizophrenia: Relationship to Anhedonia.
    Neuropsychopharmacology. 2015 Dec 28. doi: 10.1038/npp.2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: